newsfilter
← Latest News
PR Newswire·

Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for...